James Pinkerton Archives


We Are In Another Frances Kelsey Moment
November 27, 2012 11:10 PM
Bending the Curve Through Cures: Dr. Kenneth L. Davis and the Further Turning of the Wheel of Healthcare Policy
October 8, 2012 9:58 PM
From the Cut Strategy to the Cure Strategy: So Now, Who Will Create the Department of Cures? Or the First Cure Enterprise Zone?
September 27, 2012 6:11 AM
The Democrats' Blitz on Medicare: Is It for Real, or Is It Just Main Stream Media Spin?
September 16, 2012 4:18 PM
From Finance to Science: The Coming Paradigm Shift in Healthcare
September 10, 2012 7:47 PM
Medical Progress vs. Cultural and Political Futility: Part Two
April 18, 2012 10:48 AM
Medical Progress vs. Political and Cultural Futility: Part One
April 14, 2012 11:10 AM
The Alzheimer's "Time Bomb" and the Supply-Side Solution
March 7, 2012 2:48 PM
The Conflict of Healthcare Visions: Bureaucrats vs. Scientists
January 8, 2012 12:28 PM
All Visions Must Pass: Donald Berwick Departs the Centers for Medicare & Medicaid Services
December 6, 2011 5:05 PM
DARPA to the rescue! If civilians have lost interest in developing cures, let the military do it.
November 28, 2011 6:31 PM
The FDA's Rejection of Avastin: Not Part of the Solution, Part of the Problem
November 19, 2011 5:49 PM
Newt Gingrich, Challenging the Conventional Wisdom on Healthcare--And Thriving as a Champion of Medical Progress
November 8, 2011 5:12 PM
Freeman Dyson Summons Up Francis Bacon to Remind Us That Science and Progress Can Blaze a Trail Right Through Ideology and Polarization
October 23, 2011 10:33 PM
Should we be bullish--or not--about Pharma? And if so, in which country?
October 20, 2011 9:04 PM
Who Will Apply Steve Jobs' "Insanely Great" Computing Vision to Medicine?
October 12, 2011 10:36 AM
The Fate of the Social Contract: Why Are Americans Once Again At Risk From Dengue Fever? Answer: Because Uncle Sam Has Other Priorities
October 3, 2011 9:36 AM
Ron Paul Meets EMTALA--and the Reality of Public Health in a Globalized World
September 23, 2011 3:41 PM
The Super Committee Faces the Challenge of Knowing the Unknowable
September 22, 2011 3:21 PM
Search
keep in touch     Follow Us on Twitter  Facebook  Facebook

Our Research

Rhetoric and Reality—The Obamacare Evaluation Project: Cost
by Paul Howard, Yevgeniy Feyman, March 2013

Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials
by Avik Roy, April 2012

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research
by Tomas J. Philipson, Eric Sun, June 2011

How Conflict-of-Interest Rules Endanger Medical Progress and Cures
by Richard A. Epstein, October 2010

Cost of Caution: The Impact on Patients of Delayed Drug Approvals
by Tomas J. Philipson, Eric Sun, June 2010

In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation
by James R. Copland, Paul Howard, March 2009


MORE REPORTS >>

Tag Cloud
Archives

Blogroll

American Council on Science and Health
in the Pipeline
Drugwonks
Pharmalot
Reason – Peter Suderman
WSJ Health Blog
The Hill’s Healthwatch
Forbes ScienceBiz
The Apothecary
EyeOnFDA
KevinMD
Marginal Revolution
Megan McArdle
LifeSci VC
Critical Condition
EconLog
In Vivo Blog
PharmaGossip
Pharma Strategy Blog
Drug Discovery Opinion